Tenderwize
Zurück zur Suche

Open House Discount Agreement for Zolmitriptan

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Zolmitriptan, ATC N02CC03

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

50 / 100

Komplexität

20 / 100

Risikofaktoren

The authority reserves the right to replace Open House agreements with exclusive discount agreements during the contrac...

No estimated value or volume is provided, so the potential business volume is unknown.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing Zolmitriptan (ATC N02CC03)
  • Non-exclusive discount agreements with uniform conditions
Vollständige Zusammenfassung anzeigen

This is an Open House (non-exclusive) discount agreement procedure by AOK Rheinland-Pfalz/Saarland for pharmaceutical products containing the active substance Zolmitriptan (ATC N02CC03). The contracting authority offers uniform, non-negotiable contracts to any interested pharmaceutical company without selection. Contracts run for a maximum of 24 months starting from June 1, 2025, with the possibility of joining on the first of any month. The procedure is explicitly stated not to be a public procurement under EU directive 2014/24/EU but is published for transparency. No estimated value is provided. Submission is paper-based only. The initial deadline for the first wave of contracts is April 30, 2025; later joiners must submit by the end of the month prior to the desired start.

Risiken

The authority reserves the right to replace Open House agreements with exclusive discount agreements during the contrac...

No estimated value or volume is provided, so the potential business volume is unknown.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Products must be authorized and marketable in Germany
  • Evidence of marketability via Lauer-Taxe listing or AMIce database extract

Administrative

  • Paper-based submission (electronic submission not allowed)

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

No award criteria specified; contracts are offered on a take-it-or-leave-it basis to all participants.

Auftraggeber

Lose (1)

LOT-0001

Open House Discount Agreement for Zolmitriptan

Non-exclusive discount agreements for Zolmitriptan (ATC N02CC03) under an Open House model. All interested pharmaceutical companies can join under uniform terms. Contracts may be terminated early if the authority awards exclusive discount agreements via a separate tendering process. The maximum contract duration is 24 months. Children's medicines according to BfArM list are excluded.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Zuschlagskriterien

No award criteria specified; contracts are offered on a take-it-or-leave-it basis to all participants.

Frist

Deadline Mar 31, 2027

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
237213-2025

Dokumente (1)

Ähnliche Ausschreibungen